Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Crohn's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02365649
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy

Who this might be right for
Crohn's Disease
AbbVie 220
Not applicableUnknownNCT04492267
What this trial is testing

Inflammatory Bowel Disease (IBD) and Covid-19 Infection

Who this might be right for
Inflammatory Bowel Disease
University Hospital, Strasbourg, France 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT05668013
What this trial is testing

Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Who this might be right for
Crohn DiseaseColitis, Ulcerative
Teva Branded Pharmaceutical Products R&D LLC 247
Early research (Phase 1)Study completedNCT01659762
What this trial is testing

A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.

Who this might be right for
Crohn's Disease
Emory University 16
Testing effectiveness (Phase 2)Ended earlyNCT03650413
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Genentech, Inc. 143
Testing effectiveness (Phase 2)Study completedNCT05013905
What this trial is testing

A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006)

Who this might be right for
Crohn Disease
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 55
Early research (Phase 1)Study completedNCT01847170
What this trial is testing

Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease

Who this might be right for
Crohn's Disease
Beth Israel Deaconess Medical Center 22
Testing effectiveness (Phase 2)Study completedNCT00740103
What this trial is testing

Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Ferring Pharmaceuticals 119
Post-approval studies (Phase 4)Ended earlyNCT02392286
What this trial is testing

Corticosteroid Dosage for Crohn's Disease Flare

Who this might be right for
Crohn's DiseaseInflammatory Bowel Disease
Yale University 15
Testing effectiveness (Phase 2)Ended earlyNCT03870334
What this trial is testing

Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
NImmune Biopharma 27
Large-scale testing (Phase 3)Looking for participantsNCT04844606
What this trial is testing

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Who this might be right for
Ulcerative ColitisUlcerative Colitis ChronicInflammatory Bowel Diseases+1 more
Eli Lilly and Company 150
Not applicableEnded earlyNCT03455751
What this trial is testing

Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery

Who this might be right for
Colorectal CancerDiverticular DiseaseCrohn Disease+1 more
The Cleveland Clinic 10
Testing effectiveness (Phase 2)Looking for participantsNCT07483099
What this trial is testing

LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Who this might be right for
Crohn Disease
Eli Lilly and Company 60
Not applicableEnded earlyNCT02775656
What this trial is testing

UCB Cimzia Pregnancy Follow-up Study

Who this might be right for
Rheumatoid Arthritis (RA)Crohn's Disease (CD)Psoriatic Arthritis (PsA)+1 more
UCB BIOSCIENCES, Inc. 1
Testing effectiveness (Phase 2)Ended earlyNCT03599622
What this trial is testing

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Who this might be right for
Granulomatous ColitisCrohn's DiseaseCrohn's Enteritis+1 more
Bristol-Myers Squibb 239
Not applicableStudy completedNCT05394805
What this trial is testing

Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 156
Not applicableStudy completedNCT00524537
What this trial is testing

A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 5,025
Large-scale testing (Phase 3)Study completedNCT02394028
What this trial is testing

Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Hoffmann-La Roche 1,035
Not applicableLooking for participantsNCT06023030
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

Who this might be right for
Crohn's Disease
AbbVie 240
Large-scale testing (Phase 3)WithdrawnNCT03905109
What this trial is testing

Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients

Who this might be right for
Crohn Disease
Abivax S.A.
Next Page